Oncology & Cancer

Disappointment as breast cancer drug not approved on NHS

The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health and Care Excellence ...

Oncology & Cancer

Special offers fuel obese shoppers

Shoppers whose supermarket trolleys are stacked with food and drink offered on special promotions have more than a 50 percent increased chance of being obese, according to a Cancer Research UK report published today.

Medications

US drug prices are costing us more than we think

Aduhelm, the first new Alzheimer's drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, ...

page 27 from 40